-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Pieris Pharmaceuticals, Inc. annual/quarterly Current Income Tax Expense (Benefit) history and growth rate from Q3 2013 to Q3 2014.
- Pieris Pharmaceuticals, Inc. Current Income Tax Expense (Benefit) for the quarter ending September 30, 2014 was $0.000.
- Pieris Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $0.000.
- Pieris Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $0.000.
- Pieris Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
Current Income Tax Expense (Benefit), Quarterly (USD)